Dogwood Therapeutics DWTX Other operating expenses
Other operating expenses at other companies
Other financials
Where this comes from
Reported directly by Dogwood Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:OperatingExpenses.
The official record: Dogwood Therapeutics’s 10-Q, filed May 15, 2026, on SEC EDGAR. View the filing →
Ask your AI about Dogwood Therapeutics's other operating expenses.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Dogwood Therapeutics's other operating expenses?
- Dogwood Therapeutics (DWTX) reported other operating expenses of $5.08M in Q1 2026.
- How has Dogwood Therapeutics's other operating expenses changed year-over-year?
- Dogwood Therapeutics's other operating expenses increased by 14.6% year-over-year, from $4.43M to $5.08M.
- What is the long-term trend for Dogwood Therapeutics's other operating expenses?
- Over 4 years (2021 to 2025), Dogwood Therapeutics's other operating expenses has grown at a 15.6% compound annual growth rate (CAGR), from $15.64M to $27.97M.
- What does other operating expenses mean?
- Residual operating expenses not classified into specific categories, serving as a catch-all for miscellaneous operating costs.